BeiGene (SHSE:688235) 3-Year Book Growth Rate : -7.10% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is BeiGene 3-Year Book Growth Rate?

BeiGene's Book Value per Share for the quarter that ended in Dec. 2023 was ¥18.58.

During the past 12 months, BeiGene's average Book Value per Share Growth Rate was -19.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was -7.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was 12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 11 years, the highest 3-Year average Book Value per Share Growth Rate of BeiGene was 42.10% per year. The lowest was -7.10% per year. And the median was 27.00% per year.

Competitive Comparison of BeiGene's 3-Year Book Growth Rate

For the Biotechnology subindustry, BeiGene's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BeiGene's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BeiGene's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where BeiGene's 3-Year Book Growth Rate falls into.

BeiGene 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

BeiGene (SHSE:688235) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

BeiGene 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of BeiGene's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

BeiGene (SHSE:688235) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeiGene Ltd (SHSE:688235) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

BGNE:USA 06160:Hong Kong 49BA:Germany B1GN34:Brazil

Address

c/o Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, Grand Cayman, CYM, KY1-1108

Website

https://www.beigene.com

BeiGene Ltd is a commercial-stage biotechnology company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1. Its geographical segments are China, the United States, and the Rest of the world.

BeiGene (SHSE:688235) Headlines

No Headlines